Whether it’s making every shot, grabbing every rebound or feeling like you can’t be beat — NBA players explain ‘What It’s Like’ when you’ve reached that elite feeling of being in the zone.
Grupo Aeromexico S.A.B. de C.V. ("Aeromexico") (BMV: AEROMEX) today reported February 2021 operational results.
The Senate is expected to pass the $1.9 trillion package — and Democrats are working to keep all members on board.
VANCOUVER, British Columbia, March 05, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has increased and completed its previously announced non-brokered private placement of units (the "Units"), and has issued an aggregate of 11,260,040 Units at the price of CDN $0.25 per Unit, raising gross proceeds of CDN $2,815,010 (the “Offering”). Each Unit is comprised of one Class A common share (a “Share”) and one Share purchase warrant. Each whole warrant will entitle the holder to acquire one additional Share at a price of CDN $0.40 per Share until March 5, 2023 (the “Expiry Date”). At any time after July 5, 2021 and prior to the Expiry Date, the Warrants are subject to accelerated expiry in the event the daily volume weighted average trading price of the Common Shares equals or exceeds CAD $0.80 on the Canadian Securities Exchange (the “Exchange”) (or such other exchange on which the Common Shares may be traded), for ten (10) consecutive trading days (the “Triggering Event”), in which case, the Company may accelerate the expiry date of the Warrants by giving notice via news release within ten (10) days of the Triggering Event to the holders thereof and, in such case, the Warrants will expire on the 30th day after the date on which the news release is disseminated by the Company.In connection with the Offering, the Company has paid cash commissions in the aggregate amount of CDN $161,400, being 8% of the aggregate proceeds raised from the sale of Units to purchasers introduced by eligible finders. In addition, the Company has issued 645,600 finder’s warrants (the “Finders’ Warrants”), being 8% of the number of Units sold under the Offering to purchasers introduced by such finders. Each Finders’ Warrant entitles the holder to purchase one Unit at a price of CDN $0.40 per Unit until March 5 2023. All securities issued in connection with the Offering are subject to a statutory hold period of four months, expiring July 5, 2021 in accordance with applicable securities legislation. The net proceeds of the Offering will be used to fund the Company’s general corporate purposes. About Algernon Pharmaceuticals Inc. Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. CONTACT INFORMATION Christopher J. MoreauCEOAlgernon Pharmaceuticals Inc.604.398.4175 ext 701 info@algernonpharmaceuticals.cominvestors@algernonpharmaceuticals.comwww.algernonpharmaceuticals.com. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY DISCLAIMER STATEMENT: No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
The actor married Riko Shibata on February 16
Image source: The Motley Fool. INmune Bio, Inc. (NASDAQ: INMB)Q4 2020 Earnings CallMar 04, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings, and welcome to the INmune Bio fourth-quarter 2020 earnings conference call.
All forward-looking statements made on this call are made as of the date hereof, and Silvercrest assumes no obligation to update them. Silvercrest ended the fourth quarter of 2020 and the year on a high note, paving the way for a very good start to 2021, with a potential new high revenue run rate.
BALY earnings call for the period ending December 31, 2020.
Dylan Canoville spun through the air, flushed home a 360-degree slam dunk, slapped the floor and then roared. Calvary Christian Academy’s bench emptied as the final horn sounded and its state-championship comeback was complete. Canoville’s teammates surrounded their senior leader beneath the basket at the RP Funding Center after Calvary Christian finally pulled out an overtime thriller against Spring Hill Bishop McLaughlin Catholic in the Class 3A championship
Mar. 5—NORTH DARTMOUTH, Mass. — The Keene State men's basketball team was dealt a lopsided 108-68 defeat by the University of Massachusetts-Dartmouth in the Little East Conference tournament championship game Thursday night at the Tripp Athletic Center. Not only did UMass-Dartmouth (8-2) amass a season-best 58 percent shooting performance and make 15-of-32 (47 percent) from long range, the ...
The Board of Directors of Source Capital, Inc. (NYSE: SOR) (the "Fund"), today approved a revision to the Fund’s regular monthly distribution rate announced last week by increasing the annualized distribution rate to $2.22 per common share (18.5 cents per common share monthly) for each of the next three months as follows:
Outfielder Jarrod Dyson returned to the Kansas City Royals, finalizing a $1.5 million, one-year contract on Friday. The 36-year-old, who helped the Royals win the 2015 World Series, can earn $250,000 in performance bonuses for plate appearances: $50,000 each for 350, 400, 450, 500, and 550. Dyson was a 50th-round pick by the Royals in the 2006 amateur draft and played for the Royals from 2010-16.
New York, New York--(Newsfile Corp. - March 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of QuantumScape Corporation f/k/a Kensington Capital Acquisition Corp. (NYSE: QS) alleging that the Company violated federal securities laws.Class Period: November 27, 2020 and December 31, 2020Lead Plaintiff Deadline: March 8, 2021Learn more about your recoverable losses in QS:http://www.kleinstocklaw.com/pslra-1/quantumscape-corporation-f-k-a-kensington-capital-acquisition-corp-loss-submission-form?id=13389&from=5The filed complaint alleges that QuantumScape Corporation f/k/a Kensington Capital ...
Liz Loza and Dalton Del Don discuss the role of Minnesota Vikings tight end Irv Smith Jr. in 2021 after the release of starter Kyle Rudolph. Hear the full conversation on the Yahoo Fantasy Football Forecast on Apple Podcasts, Spotify, or wherever you listen to podcasts.
So Bryants strong ability in the outfield he has started at all three spots in his career gives the manager several options for matching up against tough lefties or covering an injury to a starter.
Republicans are taking a page from their opposition to Barack Obama’s costly economic recovery package years ago by portraying the COVID-19 relief bill as too big and too bloated. (March 5)
My neck had gotten so stiff a few months ago that I was grimacing in pain just from tipping my head to one side or twisting around. All the neck stretches and foam-rolling in the world wasn't making a lasting difference.
Evil Inside is a first-person psychological horror game. After the death of his mother and the arrest of his father for it, Mark decides to contact her using the Spiritual board. But it fades away, and here is when all begins... Mark will face his greatest fears to discover the truth.
There are times when the film rises above its laboured script to recapture some of the wit of the original.
The Gamecocks are off to their best start since they won 10 straight in 2016.
Much has changed, from social media to the pandemic, but much didn't when the original cast of "The Real World" gathered for a Paramount+ reunion.
Yahoo Home